BTK-IN-11

Modify Date: 2024-01-02 18:45:29

BTK-IN-11 structure	Common Name	BTK-IN-11
	CAS Number	2765852-46-6	Molecular Weight	487.94
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₆H₂₂ClN₅O₃	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of BTK-IN-11

BTK-IN-11 is a potent inhibitor of BTK. BTK plays an important role in signaling mediated by B cell antigen receptor (BCR) and Fcγreceptor (FcγR) in B cells and myeloid cells, respectively. BTK-IN-11 has the potential for the research of related diseases, especially autoimmune diseases, inflammatory diseases or cancer (extracted from patent WO2022063101A1, compound Z2)[1].

Name	BTK-IN-11

Description	BTK-IN-11 is a potent inhibitor of BTK. BTK plays an important role in signaling mediated by B cell antigen receptor (BCR) and Fcγreceptor (FcγR) in B cells and myeloid cells, respectively. BTK-IN-11 has the potential for the research of related diseases, especially autoimmune diseases, inflammatory diseases or cancer (extracted from patent WO2022063101A1, compound Z2)[1].
Related Catalog	Research Areas >> Cancer Research Areas >> Inflammation/Immunology Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Btk
References	[1]. Fusheng Zhou, et al. Aroyl substituted tricyclic compound, preparation method therefor and use thereof. Patent WO2022063101A1.

Molecular Formula	C₂₆H₂₂ClN₅O₃
Molecular Weight	487.94

BTK-IN-11

Use of BTK-IN-11

Names

BTK-IN-11 Biological Activity

Chemical & Physical Properties